Latest: Indogulf Cropsciences Ltd Q2 FY27 (Jul–Sep 2026) results →This page is Q1 FY27 (Apr–Jun 2026).All Q1 FY27 results →
IC

Indogulf Cropsciences Ltd

Q1 FY27Fertilizers & Agrochemicals

Indogulf Cropsciences Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹67
Market cap₹427 Cr
P/E11.1
Updated18 Sept 2026
Read3 min read

The short version

- With existing capacity, peak revenue can reach Rs. Indogulf expects sustained top-line and bottom-line growth over the medium to long term, driven by product mix improvement and higher margin specialty products like biologicals and plant nutrition.

From Indogulf Cropsciences Ltd's Q1 FY27 earnings-call transcript · updated 18 Sept 2026.

Revenue & Sales Performance

  • With existing capacity, peak revenue can reach Rs. 1100-1200 crores; with expanded capacity, turnover can target Rs. 1800+ crores within 2-3 years.
  • Management focuses on expanding high-margin product mix, including biologicals and plant nutrition, which grew from 11% to 22% of brand sales recently.
  • International expansion is ongoing with registrations in various countries (e.g., Taiwan, Sri Lanka, Saudi Arabia) to add new markets.
  • The company is investing in backward integration, manufacturing efficiency, and working capital optimization to support margin and volume growth.

2 more points from Indogulf Cropsciences Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Indogulf Cropsciences Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Indogulf Cropsciences is continuing to invest in manufacturing infrastructure, including:
  • Expansion at the Barwasni plant.
  • Development of a new Dry Formulation (DF) manufacturing facility.
  • Capital work-in-progress stood at Rs. 76.4 crores in FY26, up from Rs. 57.1 crores in FY25, reflecting ongoing investments.
  • The company’s capacity utilization increased to 70% in Q1 FY27 with the current expanded capacity capable of supporting a top line of around Rs. 1800 crores over the next few years.
  • Growth-focused investments include product development, distribution network expansion, and export capabilities to build a stronger platform for medium-to-long-term growth.

2 more points from Indogulf Cropsciences Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Indogulf Cropsciences Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Indogulf Cropsciences Ltd said on order book & pipeline — free account, 30 seconds.

Indogulf Cropsciences Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹256 Cr, net profit ₹26 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Indogulf Cropsciences Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Indogulf Cropsciences Ltd Q1 FY27 results?

- With existing capacity, peak revenue can reach Rs. Indogulf expects sustained top-line and bottom-line growth over the medium to long term, driven by product mix improvement and higher margin specialty products like biologicals and plant nutrition.

What is Indogulf Cropsciences Ltd share price analysis?

Indogulf Cropsciences Ltd currently shows a neutral. The stock trades at a P/E of 11.1 with a market cap of ₹427 Cr. Investors should review the full earnings analysis for detailed insights.

Is Indogulf Cropsciences Ltd planning capital expenditure?

Indogulf Cropsciences is continuing to invest in manufacturing infrastructure, including: - Expansion at the Barwasni plant. - Development of a new Dry Formulation (DF) manufacturing facility. - Capital work-in-progress stood at Rs.

Keep Indogulf Cropsciences Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.